Archives of Physical Medicine and Rehabilitation
Volume 85, Issue 7 , Pages 1070-1075, July 2004

The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort study 1

Presented in part at the Academy of Physical Medicine and Rehabilitation’s 63rd Annual Assembly, November 24, 2002, Orlando, FL.

  • Richard L Harvey, MD

      Affiliations

    • Rehabilitation Institute of Chicago, Chicago, IL, USA
    • Department of Physical Medicine and Rehabilitation, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
    • Corresponding Author InformationReprint requests to Richard L. Harvey, MD, The Rehabilitation Institute of Chicago, 345 E Superior St, Chicago, IL 60611, USA
  • ,
  • Linda L Lovell, BS

      Affiliations

    • Rehabilitation Institute of Chicago, Chicago, IL, USA
  • ,
  • Nicole Belanger, MD

      Affiliations

    • Fletcher Allen Health Care Center, Burlington, VT, USA
  • ,
  • Elliot J Roth, MD

      Affiliations

    • Rehabilitation Institute of Chicago, Chicago, IL, USA
    • Department of Physical Medicine and Rehabilitation, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

Abstract 

Harvey RL, Lovell LL, Belanger N, Roth EJ. The effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism during stroke rehabilitation: a historical cohort study. Arch Phys Med Rehabil 2004;85:1070–5.

Objective

To determine the effectiveness of anticoagulant and antiplatelet agents in preventing venous thromboembolism (VTE) during stroke rehabilitation.

Design

Historical cohort study.

Setting

Acute inpatient rehabilitation hospital.

Participants

Consecutive patients (N=1506) with ischemic and hemorrhagic stroke admitted for rehabilitation.

Interventions

Documented use of anticoagulants (warfarin or anticoagulant doses of heparin), heparin in prophylactic doses, and antiplatelet agents.

Main outcome measure

Occurrence of deep vein thrombosis detected by ultrasound or venography or pulmonary embolism detected by ventilation perfusion scan, spiral computed tomography, or pulmonary angiography.

Results

Fifty-eight VTE events occurred (3.9% incidence or 1.36 events per 1000 patient days), with higher risk in patients with severe stroke. Only therapeutic anticoagulation had a statistically significant protective effect for VTE risk in univariate analysis (odds ratio [OR]=.44; 95% confidence interval [CI], .20–.98). After adjusting for multiple medication use and other factors, including age, stroke onset to admission interval, length of rehabilitation stay, cause of stroke, and admission National Institutes of Health Stroke Scale score, therapeutic anticoagulation gave strong protection against VTE (OR=.37; 95% CI, .15–.88), followed by heparin (OR=.48; 95% CI, .23–.98) but not by antiplatelet agents (OR=.79; 95% CI, .40–1.57). No medications were associated with significant bleeding complications.

Conclusions

Use of therapeutic anticoagulants or prophylactic heparin prevented VTE in stroke patients during inpatient rehabilitation.

Keywords:  Anticoagulants, Cerebrovascular accident, Pulmonary embolism, Rehabilitation, Venous thrombosis

 
  • 1 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the author(s) or on any organization with which the author(s) is/are associated.

 Supported by the National Institute on Disability and Rehabilitation Research, US Department of Education (grant nos. H133B30024, H133B980021), through the Rehabilitation Research and Training Center on Enhancing Quality of Life of Stroke Survivors, and the National Institutes of Health (grant no. NIH HD-01097-01A1), through the Rehabilitation Scientist Research Training Program.

PII: S0003-9993(03)01175-4

doi:10.1016/j.apmr.2003.09.012

Archives of Physical Medicine and Rehabilitation
Volume 85, Issue 7 , Pages 1070-1075, July 2004